Elizabeth J. Barredo

• 2025 President’s Club Winner.
• Support cardiovascular patient access by guiding acquisition pathways, reimbursement education, and account pull-through across hospital systems, community practices, specialty pharmacies, distributors, infusion centers, and patient service resources.
• Facilitated injectable product access by coordinating with hospital systems, community accounts, contracted specialty pharmacies, distributors, infusion centers, and patient service centers.
• Educated accounts on coverage, prior authorizations, appeals, reimbursement processes, claims submissions, procedures, and coding requirements across commercial and government payers.
• Served as reimbursement subject matter expert for field partners, including sales representatives, institutional account managers, and area business leaders.
• Founded national “ARMs in Arm” committee to strengthen reimbursement best-practice sharing, field collaboration, and access support across teams.
• Completed Account Management Development Program.

Drove Entresto growth and advanced Leqvio launch execution by engaging cardiology, nephrology, and primary care accounts in Broward County.

• Exceeded Leqvio goals, achieving 142% in IC2-22, 137% in IC3-22, and 139% in IC2-23.
• Delivered highest area-team Entresto growth in IC2-23, with 22.2% TRx growth and 33% NRx growth.
• Achieved Entresto goals across multiple cycles, including 125% in IC3-22 and 101.96% in IC2-21.
• Earned 2022 Performance Award and Star Award for Leqvio launch execution, field engagement, and account impact.
• Led access/reimbursement and regional action initiatives while participating in Women in Leadership Mentor Circle.

• Grew territory performance and supported Alinia relaunch across gastroenterology, functional medicine, and infectious disease from Broward to Indian River County.
• Led Southeast Reimbursement Committee in 2020 and collaborated on policy and coverage-change initiatives.
• Completed Field Reimbursement Management training rotation.
• Established local specialty pharmacy solution to improve prescription coverage and support specialty pharmacy pull-through.

• Turned around underperforming territory, driving Synagis growth through specialty pharmacy coordination and supporting FluMist relaunch across pediatric, pulmonary, neonatal, hospital, and public health accounts.
• Maximized Synagis pull-through through physician, specialty pharmacy, managed-care, and hub coordination.
• Created Buy & Bill acquisition pathways and achieved up to 121% of FluMist quota.
• Exceeded Synagis goals across multiple years and earned East Region Top Performer recognition for 105 patient enrollments.

• Drove prescription growth for Avandia, Coreg, and Augmentin by engaging endocrinology and cardiology providers, leading speaker programs, and strengthening market penetration.
• Earned 2005 Diamond Tier national sales recognition.
• Ranked #4 of 50 in the region for overall portfolio performance.
• Achieved top regional rankings, including #1 for Augmentin ES and #3 for Augmentin XR.

• Exceeded performance expectations while promoting the respiratory portfolio to pediatricians, pulmonologists, allergists, and family practitioners.
• Exceeded 100% of product portfolio quota for three consecutive years.
• Ranked #3 in the region for overall sales performance.
• Increased Pulmicort Turbuhaler sales by 220% and secured formulary status for a territory hospital product.